182 related articles for article (PubMed ID: 12740857)
1. Diastereoselective solution and multipin-based combinatorial array synthesis of a novel class of potent phosphinic metalloprotease inhibitors.
Makaritis A; Georgiadis D; Dive V; Yiotakis A
Chemistry; 2003 May; 9(9):2079-94. PubMed ID: 12740857
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.
Matziari M; Beau F; Cuniasse P; Dive V; Yiotakis A
J Med Chem; 2004 Jan; 47(2):325-36. PubMed ID: 14711305
[TBL] [Abstract][Full Text] [Related]
3. Active methylene phosphinic peptides: a new diversification approach.
Matziari M; Nasopoulou M; Yiotakis A
Org Lett; 2006 May; 8(11):2317-9. PubMed ID: 16706515
[TBL] [Abstract][Full Text] [Related]
4. Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.
Vassiliou S; Mucha A; Cuniasse P; Georgiadis D; Lucet-Levannier K; Beau F; Kannan R; Murphy G; Knäuper V; Rio MC; Basset P; Yiotakis A; Dive V
J Med Chem; 1999 Jul; 42(14):2610-20. PubMed ID: 10411481
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and activity of phosphinic tripeptide inhibitors of cathepsin C.
Mucha A; Paweł M; Hurek J; Kafarski P
Bioorg Med Chem Lett; 2004 Jun; 14(12):3113-6. PubMed ID: 15149655
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of the phosphinic analogue of thyrotropin releasing hormone.
Matziari M; Bauer K; Dive V; Yiotakis A
J Org Chem; 2008 Nov; 73(21):8591-3. PubMed ID: 18826326
[TBL] [Abstract][Full Text] [Related]
7. Development of highly potent and selective phosphinic peptide inhibitors of zinc endopeptidase 24-15 using combinatorial chemistry.
Jirácek J; Yiotakis A; Vincent B; Lecoq A; Nicolaou A; Checler F; Dive V
J Biol Chem; 1995 Sep; 270(37):21701-6. PubMed ID: 7665587
[TBL] [Abstract][Full Text] [Related]
8. A versatile annulation protocol toward novel constrained phosphinic peptidomimetics.
Nasopoulou M; Georgiadis D; Matziari M; Dive V; Yiotakis A
J Org Chem; 2007 Sep; 72(19):7222-8. PubMed ID: 17715974
[TBL] [Abstract][Full Text] [Related]
9. A convergent solution-phase synthesis of the macrocycle Ac-Phe-[Orn-Pro-D-Cha-Trp-Arg], a potent new antiinflammatory drug.
Reid RC; Abbenante G; Taylor SM; Fairlie DP
J Org Chem; 2003 May; 68(11):4464-71. PubMed ID: 12762752
[TBL] [Abstract][Full Text] [Related]
10. Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.
Reiter LA; Mitchell PG; Martinelli GJ; Lopresti-Morrow LL; Yocum SA; Eskra JD
Bioorg Med Chem Lett; 2003 Jul; 13(14):2331-6. PubMed ID: 12824028
[TBL] [Abstract][Full Text] [Related]
11. Novel hydroxamic acid-related phosphinates: inhibition of neutral aminopeptidase N (APN).
Drag M; Grzywa R; Oleksyszyn J
Bioorg Med Chem Lett; 2007 Mar; 17(6):1516-9. PubMed ID: 17270439
[TBL] [Abstract][Full Text] [Related]
12. alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.
Biasone A; Tortorella P; Campestre C; Agamennone M; Preziuso S; Chiappini M; Nuti E; Carelli P; Rossello A; Mazza F; Gallina C
Bioorg Med Chem; 2007 Jan; 15(2):791-9. PubMed ID: 17088065
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and metal binding of novel Pseudo- oligopeptides containing two phosphinic acid groups.
Ye Y; Liu M; Kao JL; Marshall GR
Biopolymers; 2008 Jan; 89(1):72-85. PubMed ID: 17910046
[TBL] [Abstract][Full Text] [Related]
14. Development of the first potent and selective inhibitor of the zinc endopeptidase neurolysin using a systematic approach based on combinatorial chemistry of phosphinic peptides.
Jirácek J; Yiotakis A; Vincent B; Checler F; Dive V
J Biol Chem; 1996 Aug; 271(32):19606-11. PubMed ID: 8702656
[TBL] [Abstract][Full Text] [Related]
15. Shortcut to fmoc-protected phosphinic pseudodipeptidic blocks.
Matziari M; Yiotakis A
Org Lett; 2005 Sep; 7(18):4049-52. PubMed ID: 16119964
[TBL] [Abstract][Full Text] [Related]
16. Chemoselective protection of solid-phase compatible Fmoc-phosphinic building blocks.
Nasopoulou M; Matziari M; Dive V; Yiotakis A
J Org Chem; 2006 Dec; 71(25):9525-7. PubMed ID: 17137389
[TBL] [Abstract][Full Text] [Related]
17. Diastereoselective synthesis of alpha,beta'-disubstituted aminomethyl(2-carboxyethyl)phosphinates as phosphinyl dipeptide isosteres.
Yamagishi T; Ichikawa H; Haruki T; Yokomatsu T
Org Lett; 2008 Oct; 10(19):4347-50. PubMed ID: 18781768
[TBL] [Abstract][Full Text] [Related]
18. Solid-phase synthesis of succinylhydroxamate peptides: functionalized matrix metalloproteinase inhibitors.
Leeuwenburgh MA; Geurink PP; Klein T; Kauffman HF; van der Marel GA; Bischoff R; Overkleeft HS
Org Lett; 2006 Apr; 8(8):1705-8. PubMed ID: 16597146
[TBL] [Abstract][Full Text] [Related]
19. A novel method for the separation of bis(alpha-hydroxyalkyl)phosphinic acid diastereoisomers via formation of novel cyclic phosphinic acids.
Kaboudin B; Haghighat H; Yokomatsu T
J Org Chem; 2006 Aug; 71(17):6604-6. PubMed ID: 16901151
[TBL] [Abstract][Full Text] [Related]
20. Conformational and solvation studies via computer simulation of the novel large scale diastereoselectively synthesized phosphinic MMP inhibitor RXP03 diluted in selected solvents.
Matziari M; Dellis D; Dive V; Yiotakis A; Samios J
J Phys Chem B; 2010 Jan; 114(1):421-8. PubMed ID: 20014753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
